REVIEW Betahistine dihydrochloride is an antivertigo drug first used for treating vertigo assosicated with Ménière's disease. It is also commonly used for patients with balance disorders, associated with Ménière's disease. Betahistine primarily acts as a histamine H1-agonist, stimulating the H1-receptors in the inner ear causes a vasodilatory effect and increased permeability in the blood vessels which results in reduced endolymphatic pressure.
REFERENCES
[1]
Schmidt JT, Huizing EH. The clinical drug trial in Menière's disease with emphasis on the effect of betahistine SR. Acta Otolaryngol Suppl. (1992) 497: 1-189.
[2]
Guth PS. The pharmacology of betahistine in the context of the vestibular system. Acta Otorhinolaryngol Ital. (2001) Jun;21(3 Suppl 66): 16-23.
[3]
Lacour, Michel; van de Heyning, Paul H.; Novotny, Miroslav; Tighilet, Brahim. Betahistine in the treatment of Meniere's disease. Neuropsychiatric Disease and Treatment. (2007) 3(4): 429-440.
[4]
Walter, L. A.; Hunt, Wm. H.; Fosbinder, Russell J. beta-(2- and 4-Pyridylalkyl)amines Journal of the American Chemical Society (1941), 63, 2771-3.
All products are stocked and shipped from the SF Bay, California, USA via FedEx, UPS or DHL.
All batches backed with full quality assurance.
⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.
Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.